Amid health concerns, FDA reviews safety of several heavily used anemia drugs.
Tuma
Rabiya S
RS
D004921:Erythropoietin / Q000009:adverse effects*; D006801:Humans; D007880:Legislation, Drug; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins; D014481:United States; D014486:United States Food and Drug Administration
D011994:Recombinant Proteins; D004921:Erythropoietin